SA

Sidra Ahmad

Active Director Director DIN 08022966
DIN 08022966 First appointment Dec 2017 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value •••• Premium profile

About Sidra Ahmad

Data last updated:

Sidra Ahmad is a Director at Affan Biochem Private Limited (since 2017). The company operates in Business Services. Affan Biochem Private Limited reported revenue of ₹1.8 Lakh (FY 2024).

DIN 08022966
Primary Designation Director
Industry Business Services
First Appointment 27 Dec 2017
Oldest Company Age 8 yrs
Largest company Affan Biochem Private Limited · ₹1.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Affan Biochem Private Limited U74999BR2017PTC036697
Director27 Dec 20172017₹1.8 Lakh (FY 2024)Active

Board colleagues of Sidra Ahmad

Directorship timeline

Open interactive timeline →
Affan Biochem Private Limited
Premium access

Shareholding and investment profile for Sidra Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sidra Ahmad

Sidra Ahmad currently holds 1 directorship: Affan Biochem Private Limited (Director, since 27 Dec 2017, revenue ₹1.8 Lakh (FY 2024)).

Sidra Ahmad was first appointed on 27 Dec 2017 as Director at Affan Biochem Private Limited.

The current boards of Sidra Ahmad's companies include Mohammad Akram Danish (Affan Biochem Private Limited), Mohd Ashar Uz Zaman (Affan Biochem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available